Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 286
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03897127 | Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics | ||
| NCT04323254 | Language of Sleepiness | ||
| NCT04447846 | Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome | ||
| NCT01485770 | A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness | ||
| NCT06217536 | Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas | ||
| NCT05099666 | Lurbinectedin + Doxorubicin In Leiomyosarcoma | ||
| NCT00788892 | Trial of CPX-351 in Newly Diagnosed Elderly AML Patients | ||
| NCT00931164 | Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO) | ||
| NCT03572764 | CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome | ||
| NCT01080820 | A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers | ||
| NCT02348593 | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" | ||
| NCT00713817 | A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain | ||
| NCT04133480 | Investigation of Cognitive Outcomes With Cannabidiol Oral Solution | ||
| NCT01898520 | A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years | ||
| NCT05122650 | A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) | ||
| NCT01241344 | Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease | ||
| NCT02953548 | Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) | ||
| NCT02257684 | A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) | ||
| NCT01599234 | A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis | ||
| NCT02607891 | A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy | ||
| NCT00780182 | Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers | ||
| NCT05024552 | Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML | ||
| NCT03030599 | A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy | ||
| NCT04652115 | Defibrotide for the Treatment of Severe COVID-19 | ||
| NCT03555955 | A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 | ||
| NCT02596997 | Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease | ||
| NCT00670696 | A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel | ||
| NCT00793598 | CMX001 in Post-transplant Patients With BK Virus Viruria | ||
| NCT05850676 | Disentangling the Role of Depression in Hypersomnia | ||
| NCT02238925 | An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients | ||
| NCT01606176 | A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin | ||
| NCT06108050 | JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors | ||
| NCT00086281 | Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients | ||
| NCT01843634 | Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia | ||
| NCT02167685 | The Chimerix CMX001 Registry | ||
| NCT04578444 | An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer | ||
| NCT03575325 | Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia | ||
| NCT04541082 | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | ||
| NCT01643408 | A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy | ||
| NCT05288283 | Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures | ||
| NCT02544763 | A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | ||
| NCT01696084 | Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia | ||
| NCT01217112 | GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes | ||
| NCT02006628 | A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder | ||
| NCT00711880 | A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia. | ||
| NCT03849456 | Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder | ||
| NCT05027139 | A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer | ||
| NCT05476939 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | ||
| NCT01769170 | A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients | ||
| NCT00710424 | A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy |
